{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "pediatric_use": [
        "DO NOT USE ON CHILDREN UNDER 12 YEARS OF AGE UNLESS DIRECTED BY A DOCTOR."
      ],
      "effective_time": "20181009",
      "inactive_ingredient": [
        "INACTIVE INGREDIENTS: C13-14 ISOPARAFFIN, CETYL ALCOHOL, ETHYLHEXYLGLYCERIN, ETHYLHEXYL STEARATE, GLYCERIN, GLYCERYL STEARATE, GLYCOLIC ACID, ISOPROPYL MYRISTATE, LAURETH-7, NIACINAMIDE, PANTOTHENIC ACID, PEG-100 STEARATE, PHENOXYETHANOL, POLYACRYLAMIDE, PYRIDOXINE HCL, SODIUM HYDROXIDE, SODIUM METABISULFITE, TETRAHEXYLDECYL ASCORBATE, WATER (AQUA), XANTHAN GUM."
      ],
      "purpose": [
        "PURPOSE: SKIN LIGHTENING"
      ],
      "keep_out_of_reach_of_children": [
        "KEEP OUT OF REACH OF CHILDREN."
      ],
      "warnings": [
        "WARNINGS: AVOID CONTACT WITH EYES. SOME USERS MAY EXPERIENCE MILD SKIN IRRITATION."
      ],
      "questions": [
        "QUESTIONS? 1-323-733-7033"
      ],
      "spl_product_data_elements": [
        "I-MAX LIGHTENING 5 HYDROQUINONE C13-14 ISOPARAFFIN CETYL ALCOHOL ETHYLHEXYLGLYCERIN ETHYLHEXYL STEARATE GLYCERIN GLYCERYL MONOSTEARATE GLYCOLIC ACID ISOPROPYL MYRISTATE LAURETH-7 NIACINAMIDE PANTOTHENIC ACID PEG-100 STEARATE PHENOXYETHANOL POLYACRYLAMIDE (10000 MW) PYRIDOXINE HYDROCHLORIDE SODIUM HYDROXIDE SODIUM METABISULFITE TETRAHEXYLDECYL ASCORBATE WATER XANTHAN GUM HYDROQUINONE HYDROQUINONE"
      ],
      "other_safety_information": [
        "THIS PRODUCT IS NOT INTENDED FOR USE IN THE PREVENTION OF SUNBURN AND CONTAINS AN ALPHA HYDROXY ACID (AHA) THAT MAY INCREASE YOUR SKIN'S SENSITIVITY TO THE SUN AND PARTICULARLY THE POSSIBILITY OF SUNBURN. SUN EXPOSURE SHOULD BE LIMITED BY USING A SUNSCREEN AGENT OR PROTECTIVE CLOTHING TO COVER BLEACHED SKIN AFTER TREATMENT IS COMPLETED TO PREVENT DARKENING FROM REOCCURING."
      ],
      "openfda": {},
      "version": "6",
      "dosage_and_administration": [
        "DIRECTIONS: ADULTS: APPLY A SMALL AMOUNT AS A THIN LAYER ON THE AFFECTED AREA TWICE DAILY, OR USE AS DIRECTED BY A DOCTOR. IF NO IMPROVEMENT IS SEEN AFTER 3 MONTHS OF TREATMENT, USE OF THIS PRODUCT SHOULD BE DISCONTINUED. LIGHTENING EFFECT OF THIS PRODUCT MAY NOT BE NOTICEABLE WHEN USED ON VERY DARK SKIN. CHILDREN UNDER 12 YEARS OF AGE: DO NOT USE UNLESS DIRECTED BY A DOCTOR."
      ],
      "stop_use": [
        "IF IRRITATION BECOMES SEVERE, STOP USE AND CONSULT A DOCTOR."
      ],
      "package_label_principal_display_panel": [
        "5_Lightening_LBL"
      ],
      "indications_and_usage": [
        "USES: FOR THE GRADUAL FADING OF DARK AREAS OF THE SKIN."
      ],
      "set_id": "e874f160-1f05-4f53-8e41-8d41c2b441d8",
      "id": "8c9b94d9-1ae4-4def-bdb0-78aeba442a31",
      "active_ingredient": [
        "ACTIVE INGREDIENTS: HYDROQUINONE USP 2%"
      ]
    }
  ]
}